Boon or bane anti-tumor necrosis factor therapy complicated by Listeria monocytogenes meningitis culminating in colectomy for ulcerative colitis

Anti-tumor necrosis factor (TNF) biologics have revolutionized the management of inflammatory bowel diseases (IBDs) by promoting mucosal healing and delaying surgical intervention in ulcerative colitis (UC).